Skip to main content

GE Healthcare spinoff likely shelved for 2019

Less than one month after General Electric’s CEO said a spinoff of GE Healthcare remained on track for this year, the parent company halted that action by announcing the $21 billion sale of GE Healthcare’s BioPharma unit.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.